Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ombretta Melaiu
PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 And, Combined With HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma
Clinical Cancer Research
Cancer Research
Oncology
Tumor-Infiltrating T Cells and PD-L1 Expression in Childhood Malignant Extracranial Germ-Cell Tumors
OncoImmunology
Oncology
Allergy
Immunology
Related publications
PD-L1 Expression Combined With Microsatellite Instability/Cd8+ Tumor Infiltrating Lymphocytes as a Useful Prognostic Biomarker in Gastric Cancer
Scientific Reports
Multidisciplinary
PD-L1 Is a Direct Target of Cancer-Foxp3 in Pancreatic Ductal Adenocarcinoma (PDAC), and Combined Immunotherapy With Antibodies Against PD-L1 and CCL5 Is Effective in the Treatment of PDAC
Signal Transduction and Targeted Therapy
Cancer Research
Genetics
ROR2 Is a Novel Prognostic Biomarker and a Potential Therapeutic Target in Leiomyosarcoma and Gastrointestinal Stromal Tumour
Journal of Pathology
Forensic Medicine
Pathology
JMJD6 Is a Tumorigenic Factor and Therapeutic Target in Neuroblastoma
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Skp2 Is a Promising Therapeutic Target in Breast Cancer
Frontiers in Oncology
Cancer Research
Oncology
P1.03-24 TMPRSS4: A Novel Prognostic Biomarker and Therapeutic Target in NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
sCLU as Prognostic Biomarker and Therapeutic Target in Osteosarcoma
Bioengineered
Applied Microbiology
Biotechnology
Medicine
Bioengineering
The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Polo-Like Kinase 1 Is a Therapeutic Target in High-Risk Neuroblastoma
Clinical Cancer Research
Cancer Research
Oncology
